ProfileGDS5822 / ILMN_2600043
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 67% 73% 63% 73% 65% 67% 68% 66% 57% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 140.867
GSM1276600PDAC Late Ablation Control 269.973
GSM1276601PDAC Late Ablation Control 341.663
GSM1276602PDAC Late Ablation 164.873
GSM1276603PDAC Late Ablation 239.565
GSM1276604PDAC Late Ablation 345.967
GSM1303940PDAC Late Ablation_anti-CTLA4 140.968
GSM1303941PDAC Late Ablation_anti-CTLA4 251.966
GSM1303942PDAC Late Ablation_anti-CTLA4 333.157